Hydroxyurea is a usually well-tolerated cytostatic agent, but its side effects include cutaneous lesions that appear after several years of maintenance therapy with hydroxyurea. The reported incidence of such adverse reactions varies from 10 to 35%; in our Center it is 2%. We describe a patient with
β¦ LIBER β¦
Hemarthrosis secondary to heparin therapy
β Scribed by Arnold L. Katz; F. Paul Alepa
- Publisher
- John Wiley and Sons
- Year
- 1976
- Tongue
- English
- Weight
- 100 KB
- Volume
- 19
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Early cutaneous lesions secondary to hyd
β
Radaelli, Franca; Calori, Rossella; Faccini, Paola; Maiolo, Anna Teresa
π
Article
π
1998
π
John Wiley and Sons
π
English
β 86 KB
π 1 views
Pancytopenia secondary to methotrexate t
β
Sergio Gutierrez-UreΓ±a; Jose F. Molina; Cesar O. GarcΓa; Marta L. CuΓ©llar; Luis
π
Article
π
1996
π
John Wiley and Sons
π
English
β 491 KB
π 2 views
Recovery from Aplastic Anemia Secondary
β
Stephen L. Burnstein; Harry L. Staley; John J. Calabro
π
Article
π
1977
π
John Wiley and Sons
π
English
β 210 KB
π 1 views
A case of hypophosphatemic osteomalacia
β
Frances Milat; Phillip Wong; Peter J Fuller; Lillian Johnstone; Peter G Kerr; Ja
π
Article
π
2011
π
American Society for Bone and Mineral Research
π
English
β 65 KB
## Abstract Patients with Ξ²βthalassemia major require ironβchelation therapy to avoid the complication of iron overload. Until recently, deferoxamine (DFO) was the major iron chelator used in patients requiring chronic hypertransfusion therapy, but DFO required continuous subcutaneous therapy. The
Heliox in respiratory failure secondary
β
Gideon Paret; Benny Dekel; Amir Vardi; Amir Szeinberg; Danny Lotan; Zohar Barzil
π
Article
π
1996
π
John Wiley and Sons
π
English
β 233 KB
Transient cortical blindness secondary t
β
Rebecca L. Byrd; Thomas M. Rohrbaugh; R. Beverly Raney Jr; Donald G. Norris
π
Article
π
1981
π
John Wiley and Sons
π
English
β 383 KB